Clinton Maynard toalks to Rebekah Cassidy from Ausbiotech about the proposed 15-year cap on the R&D Tax Incentive ignores the lengthy clinical trial timelines needed for complex diseases like cancer and dementia, threatening to drive vital research, manufacturing, and investment offshore.  

Clinton Maynard toalks to Rebekah Cassidy from Ausbiotech about the proposed 15-year cap on the R&amp;D Tax Incentive ignores the lengthy clinical trial timelines needed for complex diseases like cancer and dementia, threatening to drive vital research, manufacturing, and investment offshore.&nbsp;&nbsp;

Money News — the most respected business program on radio.

If you crave the latest insights into super & small business, interest rates & investment, and economics & e-commerce, then the team at Money News has everything you need to know.

Add your voice to the conversation Monday to Thursday 7pm to 8pm by calling 131 873, texting 0460 873 873, or emailing moneynews@2gb.com

Money News &mdash; the most respected business program on radio.
If you crave the latest insights into super &amp; small business, interest rates &amp; investment, and economics &amp; e-commerce, then the team at Money News has everything you need to know.
Add your voice to the conversation Monday to Thursday 7pm to 8pm by calling 131 873, texting 0460 873 873, or emailing <a href="mailto:moneynews@2gb.com">moneynews@2gb.com</a>